| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23a4e0c875bf1ac2b8a3b76517de6c7d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-109 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-68 |
| filingDate |
2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd6ea060760d0379dc9ca55c6e564a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6b7649c454e0995a2774f085bdec41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5a774c1cd42b5c40b80403cfd0c96f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3add40b8bafa70ef4edd4e4963cd3da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c699a798f1196c8d1b1a28e5ccdb3b2 |
| publicationDate |
2020-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3651810-A1 |
| titleOfInvention |
Radioluminescent nanoparticles for radiation-triggered controlled release drugs |
| abstract |
The present invention relates to novel radiation-triggered controlled release drug compositions, and methods for the preparation and use of radiation-triggered controlled release drug compositions. Radiation-triggered drug controlled release nanoparticle formulations can be used to achieve maximum bioavailability and minimized side effects of chemotherapeutic drugs in combination therapy including chemotherapy and radiotherapy of locally advanced solid tumors. |
| priorityDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |